Unguided Sacroiliac Injection: Effect on Refractory Buttock Pain in Patients With Spondyloarthropathies

NCT00829543 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2009-02-03

No results posted yet for this study

Summary

This study is designed to evaluate the efficacy and safety of guide-free sacroiliac joint (SIJ) injection in refractory sacroiliac pain due to spondyloarthropathies.

Conditions

  • Spondylarthropathy

Interventions

PROCEDURE

guide-free sacroiliac corticosteroid injection

guide-free sacroiliac injection of triamcinolone acetonide 40 mg in each sacroiliac joint

Sponsors & Collaborators

  • Tabriz University

    lead OTHER

Principal Investigators

  • Shahram Sadreddini, Rheumatology · Tabriz medical university (Rheumatology Department)

  • Shahram Sadreddini, Rheumatology · Assistant professor of Tabriz medical university

  • Mahshid Molaeefard, MD · Tehran medical university

  • Seyed-Kazem Shakouri, Physiatrist · Assistant professor of Tabriz medical university

  • Morteza Ghojazadeh, Physiologist · Assistant professor of Tabriz medical university

  • Hamid Noshad, Nephrologist · Assistant professor of Tabriz medical university

  • Mohammad-Reza Ardalan, Nephrologist · Assistant professor of Tabriz medical university

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2007-01-31
Completion
2009-02-28

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00829543 on ClinicalTrials.gov